• Emeramed 2019 January Newsletter

EmeraMed Newsletter – February 2019

February 2019 Newsletter for EmeraMed Ltd, a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator & antioxidant Irminix®